Conversely, a higher percentage of IFS patients had comorbidities, such as diabetes mellitus and hematologic malignancy, which may have led to differences in blood glucose, HbA1c, Hb levels, albumin levels, and leukopenia among these two groups. Here, GSTM1 is linked to hematologic disorder.